Background/Aims: Poor viability of transplanted mesenchymal stem cells (MSCs) within the ischemic heart limits their therapeutic potential for cardiac repair. Globular adiponectin (gAPN) exerts anti-apoptotic effects on several types of stem cells. Herein, we investigated the effect of gAPN on the MSCs against apoptosis induced by hypoxia and serum deprivation (H/ SD). Methods: MSCs exposed to H/SD conditions were treated with different concentrations of gAPN. To identify the main type of receptor, MSCs were transfected with siRNA targeting adiponectin receptor 1 or 2 (AdipoR1 or AdipoR2). To elucidate the downstream pathway, MSCs were pre-incubated with AMPK inhibitor Compound C. Apoptosis, caspase-3 activity and mitochondrial membrane potential were evaluated. Results: H/SD-induced MSCs apoptosis and caspase-3 activation were attenuated by gAPN in a concentration-dependent manner. gAPN increased Bcl-2 and decreased Bax expressions. The loss of mitochondrial membrane potential induced by H/SD was also abolished by gAPN. The protective effect Moreover, Compound C partly suppressed the anti-apoptotic effect of gAPN. Conclusions: gAPN inhibits H/SD-induced apoptosis in MSCs via AdipoR1-mediated pathway, possibly linked to the activation of AMPK. gAPN may be a novel survival factor for MSCs in the ischemic engraftment environment.
Introduction
Stem cell therapy is a promising new approach for the treatment of ischemic heart diseases [1] . Among all types of cells under investigation, mesenchymal stem cells (MSCs) are most widely studied due to the abundance of autologous sources and the ability to repair the injured myocardium [2] [3] [4] . Clinical trials revealed that injection of MSCs favorably affected the functional capacity, quality of life, and ventricular remodeling in patients with ischemic cardiomyopathy [5] . However, data indicated that there appeared to be slight improvement of left ventricular ejection fraction after MSCs transplantation for acute myocardial infarction [6, 7] . This was probably attributed to the low survival rate of MSCs after being exposed to the hostile engraftment environment with various proapoptotic or cytoxic factors [8] , that hypoxia and serum deprivation (H/SD), combining the two components of ischemic injury, induced programmed MSCs death through the mitochondrial apoptotic pathway [10] . Therefore, identifying factors that prevent this process and enhance the viability of MSCs under the harsh microenvironment in the ischemic heart could be crucial for MSCs' successful utilization in cellular therapy.
Adiponectin (APN, also known as Acrp30) is an adipocytokine predominantly expressed C-terminal domain (gAPN). As a product of proteolytic cleavage, gAPN is biologically active and more potent in physiological actions [11, 12] . Apart from its well-characterized role in fat tissue metabolism and insulin resistance [13] , accumulating evidences established the to the anti-apoptotic actions of gAPN on cardiovascular cells [18] [19] [20] . Besides, previous experiments revealed that gAPN played an important modulatory role on the survival and proliferation of several types of stem cells [21] [22] [23] [24] [25] [26] . More importantly, gAPN has recently been found to promote the proliferation and migration of MSCs [27] . Taken the anti-apoptotic and stem cell-regulatory properties together, it is reasonable to hypothesize that gAPN acts as an anti-apoptotic factor in MSCs under H/SD conditions, which might offer a solution to the Adiponectin receptor 1 and receptor 2 (AdipoR1 and AdipoR2) have been proved to mainly mediate the action of APN on target tissues [28] . AdipoR1 is abundantly expressed to the subsequent activation of various signaling pathways, especially the adenosine monophosphate-activated protein kinase (AMPK) pathway [30] . AMPK is a metabolic related protein kinase that regulates energy consumption and production, and activated AMPK limits energy utilization to ensure cell survival [31] . Moreover, AMPK is also crucial in the the impact of gAPN on the apoptosis of MSCs under H/SD conditions, and further identify the main receptor(s) and the intracellular signaling mechanisms that may mediate such actions, focusing particularly on the AMPK pathways. 
Cas ase acti it
The activity of caspase 3 was measured using the Caspase 3/CPP32 Colorimetric assay kit (Biovision, buffer on ice for 10 minutes, and centrifuged at 10,000 g for 1 minute. The supernatant was transferred to
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Cells were collected and rinsed with ice-cold PBS twice and then lysed in ice-cold lysis buffer on ice for
The proteins were then transferred to nitrocellulose membranes using dry electroblotting apparatus were added and incubated for 2 hours. After washing, the membranes were processed for analysis using an
tatistical anal sis
Data are expressed as mean ± standard deviation (SD) from at least 3 independent experiments.
comparisons via SPSS Statistics software version 22.0. value less than 0.05 was considered as statistical adiponectin receptor 1 (AdipoR1) and receptor 2 (AdipoR2) were determined by Western blot. Each column represents mean ± SD of three independent experiments. * < 0.05 versus scrambled siRNA group.
Results

Characteristics o Cs
A typical feature of apoptosis is the activation of caspases, a family of cysteine proteases that plays an essential role in this process. To specify the involvement of gAPN in the survival of MSCs after H/SD, the changes of caspase-3 activity with reference to the control values were analyzed. Results showed that exposure of MSCs to H/SD brought about an approximately 4 to 5 fold increase in the caspase-3 activity, which was inhibited by gAPN in a dose-dependent of caspase-3 was further expressed as the cleavage of pro-caspase-3 into its active subunit, cleaved caspase-3 (Cl-caspase-3), using the Western blot analysis (Fig. 3A) . Compared to the H/SD group, the cleavage of pro-caspase-3 was markedly decreased with the addition of gAPN (Fig. 3B, C) . These data suggested that gAPN dose-dependently protected MSCs from was used in subsequent experiments.
di o mainl mediated the anti a o totic e ects o
To investigate the main type of receptor that mediated the actions of gAPN, siRNAs cytometry and caspase-3 activity kit were employed as quantitative assays to decide the Fig. 5A -B, compared with the scrambled group, the knockdown of AdipoR1 resulted in a group, < 0.05) phases, whereas no obvious changes were observed with the knockdown of AdipoR2 at early (2.25 ± in scrambled group, > 0.05) phases. Suppression of both AdipoR1 and AdipoR2 expression in combination by siRNA almost abolished the protective effect of gAPN against early (8.73 H/SD group, < > 0.05) apoptosis. The differences between si-AdipoR1 group and combined knockdown of AdipoR1 and AdipoR2 group were < 0.05) than that of AdipoR2 (1.44 ± 0.32 vs. 1.08 ± 0.08 in scrambled group, > 0.05). The combined knockdown of AdipoR1 and AdipoR2 almost reversed the suppressive effect of gAPN on caspase-3 activity (3.84 ± 0.18 vs. 1.08 ± 0.08 in scrambled group, < 0.05; 3.84 ± 0.18 vs. 4.65 ± 0.84 in H/SD group, rather than AdipoR2 that mainly mediated the anti-apoptosis effect of gAPN against H/SD conditions. [14, 18, 30, [34] [35] [36] . To determine whether this signaling pathway was stimulated by gAPN in MSCs, phosphorylation of AMPK was assessed following treatment with different concentrations of gAPN under H/SD conditions for 6 hours. Results showed that gAPN induced a dose-dependent increase of phosphorylation of AMPK (p-AMPK) at Thr-172 with 0.05) (Fig. 6A) . Further, compared with the scrambled group, the knockdown of AdipoR1 partly inhibited the p-AMPK (0.75 ± 0.13 vs. 1.25 ± 0.15 in scrambled group, 0.05) (Fig. 6B ). We extended our study by examining whether activation of this pathway was critical for the anti-apoptotic actions of gAPN in MSCs. Results showed that pre-incubation with Compound C partly suppressed the anti-apoptotic effect of gAPN on MSCs, evidenced by < 0.05) < 0.05) (Fig. 7A , < 0.05) (Fig. 7C) . These results illustrated that gAPN inhibited the apoptosis of MSCs against H/SD conditions at least partly through the AMPK pathway.
elicited anti a o totic e ect ia the inhi ition o the mitochondrial related intrinsic ath a
The balance of anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bax plays an important role in the regulation of mitochondrial integrity and cell survival [37] . To ascertain whether the mitochondrial-dependent apoptotic pathway was involved in the gAPN's protective effect on MSCs, the effect of gAPN on H/SD-induced Bcl-2 and Bax expression (Fig. 8B, C) . As the loss of mitochondrial membrane potential (MMP) is regarded as one of the to a strong protection from MMP loss induced by H/SD, as determined by the reduction of 
Discussion
The therapeutic potential of MSCs for cardiac repair is hampered partly due to their low survival rate within the ischemic myocardial microenvironment into which MSCs changes relative to the control group. Each column represents mean ± SD of three independent experiments. * < 0.05 versus control group; # < 0.05 versus H/SD group; $ < 0.05 siRNA) group. are introduced [8] . Hypoxia and serum deprivation, imitating the ischemic engraftment environment, induced the apoptosis of MSCs through the mitochondrial apoptotic pathway [10] . This study found that gAPN could confer a protective effect against the above-mentioned process after binding with AdipoR1 and activating the downstream AMPK pathway. These targeting gAPN.
APN is an adipocyte-secreted protein that elicits protective effects in the vasculature and myocardium with anti-diabetic, anti-atherosclerotic and anti-apoptotic properties [17] . differentiation of several types of stem cells [21] . gAPN, the globular C-terminal domain of APN, is biologically active and easier to manufacture and administer [20, 23, 24, 38] .
effects. There is indeed precedence suggesting that APN serves as a prosurvival stem cell cells (BM-MNCs) against apoptosis triggered by staurosporine or ceramide [22] . gAPN also counteracted the apoptotic process triggered by growth factor withdrawal in murine mesoangioblasts [24] . Besides, gAPN increased the endothelial repair and angiogenesis addition, Hou M et al. showed that C1q tumor necrosis factor-related protein-3 (CTRP3), a serum deprivation was the predominant factor in this process [10] , while hypoxia alone 2 even enhanced the proliferation of MSCs [42, 43] . The resistance to hypoxia er se is largely due to the up-regulated glycolytic activities as indicated by the high-level expression of glycolytic enzymes in MSCs [44] [63, 64] lead to loss of MMP and release of cytochrome c from the mitochondria to the cytoplasm, which activates the caspase-3 effector and leads to apoptotic cell death [37, 65] .
and Bax expression [61, 66] and attenuate the mitochondrial dysfunction in diabetic heart [54] . Mitochondria in undifferentiated MSCs were maintained at a relatively low activity status [44] . Nevertheless, it was found to be highly sensitive to external environment such 
